Preeya Gupta, MD, Associate Professor of Ophthalmology at Duke University School of Medicine and member of Oyster Point Pharma’s medical advisory board, performs cataract surgery, Lasik surgery, and corneal transplantation, and conducts research on dry eye disease (DED), keratoconus, and cataract surgery. DED, which experts estimate affects more than 34 million in the United States, can cause pain, blurriness, and inflammation, can even injure your cornea.
Recent studies reveal that the damage doesn’t stop there—many individuals with DED find it harder to perform simple tasks such driving or getting dressed; experience significant pain that interferes with social relationships; and report increased anxiety, depression, and poor overall health.
Fortunately, in addition to the over-the-counter artificial tears currently available, there are several treatments on the horizon, including prescription eye drops and—surprisingly, a nasal spray—that can help. More.
